×
About 488 results

ALLMedicine™ Bullous Diseases Center

Research & Reviews  159 results

The utility of the pattern-based approach using BIOCHIP-indirect immunofluorescence in ...
https://doi.org/10.1111/cup.14368
Journal of Cutaneous Pathology; Chaitra V, Vinayagam N et. al.

Nov 30th, 2022 - Subepidermal bullous disorders (SEBD) are a heterogeneous group of vesiculobullous diseases due to antibody-mediated destruction of proteins of the dermo-epidermal junction. Direct immunofluorescence (DIF) is the gold standard for diagnosis. BIOCH...

Investigating the Morbidity of Glucocorticoid Use in Patients With Autoimmune Bullous Diseases (AIBDs)
https://clinicaltrials.gov/ct2/show/NCT05525065

Sep 19th, 2022 - This study is an multi-centre observational trial. Patients with AIBDs are recruited based on the criteria: an age of eighteen years or above; a new or established diagnosis of autoimmune bullous disease confirmed by clinical assessment, histopath...

Intravenous immunoglobulin-induced thrombocytopenia: a case report and review of the li...
https://doi.org/10.1684/ejd.2022.4271
European Journal of Dermatology : EJD; Fukuzono M, Okiyama N et. al.

Sep 7th, 2022 - Intravenous immunoglobulin (IVIG), a pooled blood product acquired from multiple healthy donors, is an effective treatment for various types of autoimmune diseases, haematological disorders, and infectious diseases. Adverse haematological events s...

Autoimmune bullous diseases in skin of color.
https://doi.org/10.1016/j.clindermatol.2022.07.002
Clinics in Dermatology; Ajayi A, Sathi S et. al.

Aug 20th, 2022 - Autoimmune bullous diseases in skin of color.|2022|Ajayi A,Sathi S,Petronic-Rosic V,|

Management of Coexisting Bullous Pemphigoid and Psoriasis: A Review.
https://doi.org/10.1007/s40257-022-00719-7
American Journal of Clinical Dermatology; Hsieh CY, Tsai TF

Aug 15th, 2022 - Psoriasis in an immune-mediated inflammatory disease and is associated with increased risk of various comorbidities, especially autoimmune bullous diseases. However, the optimal management of coexisting psoriasis and bullous pemphigoid (BP) is not...

see more →

Guidelines  1 results

Pemphigus. S2 Guideline for diagnosis and treatment--guided by the European Dermatology...
https://doi.org/10.1111/jdv.12772
Journal of the European Academy of Dermatology and Venere... Hertl M, Jedlickova H et. al.

Oct 24th, 2014 - Pemphigus encompasses a group of life-threatening autoimmune bullous diseases characterized by blisters and erosions of the mucous membranes and skin. Before the era of immunosuppressive treatment, the prognosis of pemphigus was almost fatal. Due ...

see more →

Clinicaltrials.gov  12 results

Investigating the Morbidity of Glucocorticoid Use in Patients With Autoimmune Bullous Diseases (AIBDs)
https://clinicaltrials.gov/ct2/show/NCT05525065

Sep 19th, 2022 - This study is an multi-centre observational trial. Patients with AIBDs are recruited based on the criteria: an age of eighteen years or above; a new or established diagnosis of autoimmune bullous disease confirmed by clinical assessment, histopath...

Drug Reactions Sampling (COLLECTIONTOXIDERMIES)
https://clinicaltrials.gov/ct2/show/NCT03659227

May 3rd, 2022 - Intro: Dermatology department of Henri Mondor Hospital (Creteil, France), is a reference center for toxic bullous diseases and severe cutaneous drug reactions (Stevens-Johnson syndrome (SJS), Lyell syndrome (toxic epidermal necrolysis (TEN)), gene...

A Prospective & Retrospective Study on Ectopic Lymphoid-like Structures in Chronic Skins of Autoimmune Bullous Diseases
https://clinicaltrials.gov/ct2/show/NCT04509570

Mar 16th, 2022 - The purpose of this study is to identify the presence or absence of ectopic lymph node-like structures in skin lesions of patients with autoimmune bullous disease and the subtypes of the cells deposited there. In addition, this study clarifies the...

Treatment of Bullous Pemphigoid With Avdoralimab (IPH5401), an Anti-C5aR1 Monoclonal Antibody
https://clinicaltrials.gov/ct2/show/NCT04563923

Feb 21st, 2022 - The development of Auto Immune bullous Diseases (AIBD) results from a complex interaction between innate and adaptive immune systems. Bullous pemphigoid (BP), the most frequently encountered AIBD, predominantly affects elderly patients above 70 wi...

Topical Steroids Alone or Associated With Methotrexate in Bullous Pemphigoid
https://clinicaltrials.gov/ct2/show/NCT02313870

Feb 1st, 2022 - Bullous pemphigoid (BP) is a rare mucocutaneous autoimmune bullous disorder (incidence <1/10000 / year in France) that mostly affects elderly patients. Its mortality rate is as high as 20 to 40% at one year. A study initiated by the French group f...

see more →

News  23 results

For Pemphigus, Rituximab Is First Line, Expert Says
https://www.medscape.com/viewarticle/971362

Mar 31st, 2022 - For patients presenting with moderate to severe pemphigus, the choice of initial therapy has been distilled to a single agent: rituximab. This drug is more rapidly effective, more likely to provide sustained remission, better tolerated, and lowers...

Should all skin cancer patients be taking nicotinamide?
https://www.mdedge.com/dermatology/article/233543/nonmelanoma-skin-cancer/should-all-skin-cancer-patients-be-taking
Lily Talakoub, MD, Naissan O. Wesley, MD

Dec 15th, 2020 - In 2014, I began taking care of a patient (see photo) who had developed over 25 basal cell carcinomas on her lower legs, which were surgically removed. Given the results of a 2015 study by Chen et al.

Tense Bullae on the Hands
https://www.mdedge.com/dermatology/article/219375/dermatopathology/tense-bullae-hands
Georgeanne Cornell, MD, Atieh Jibbe, MD et. al.

Mar 20th, 2020 - The Diagnosis: Epidermolysis Bullosa Acquisita Epidermolysis bullosa acquisita (EBA) is a rare autoimmune blistering disorder characterized by tense bullae, skin fragility, atrophic scarring, and milia formation. 1 Blisters occur on a noninflammato.

Persistent Pruritic Papules on the Buttocks
https://www.mdedge.com/dermatology/article/214187/autoimmune-diseases/persistent-pruritic-papules-buttocks
Emily Ileen Patton, DO, Jared E. Roberts, MD et. al.

Dec 12th, 2019 - The Diagnosis: Dermatitis Herpetiformis Dermatitis herpetiformis (DH), also known as Duhring disease, is a rare autoimmune disease. It is the cutaneous manifestation of gluten sensitivity with antibodies targeting epidermal transglutaminase.

Generalized rash following ankle ulceration
https://www.mdedge.com/familymedicine/article/201807/dermatology/generalized-rash-following-ankle-ulceration
MDedge Family Medicine;

May 30th, 2019 - IMAGE COURTESY OF: UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO At the hospital, the physicians noted that there were no lesions on the mucous membranes of the patient’s eyes, ears, nose, mouth or anus and his vital signs were within n.

see more →